Bridgebio Pharma shares owned by Summit Investment Advisors
Quarter-by-quarter ownership of Bridgebio Pharma (BBIO) shares owned by Summit Investment Advisors
from 13F filings
Historical chart of Summit Investment Advisors investment in Bridgebio Pharma
Tip: Access up to 7 years of quarterly data
All positions including Bridgebio Pharma held by Summit Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Bridgebio Pharma by Summit Investment Advisors
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $466k | 12k | 40.37 |
2023-09-30 | $300k | 11k | 26.37 |
2023-06-30 | $163k | 9.5k | 17.20 |
2023-03-31 | $136k | 8.2k | 16.58 |
2022-12-31 | $70k | 8.2k | 8.52 |
2022-09-30 | $81k | 8.2k | 9.88 |
2022-06-30 | $74k | 8.2k | 9.02 |
2022-03-31 | $83k | 8.2k | 10.12 |
2021-12-31 | $137k | 8.2k | 16.71 |
2021-09-30 | $395k | 8.4k | 46.81 |
2021-06-30 | $514k | 8.4k | 60.91 |
2021-03-31 | $471k | 7.7k | 61.54 |
2020-12-31 | $441k | 6.2k | 71.06 |
2020-09-30 | $233k | 6.2k | 37.54 |
2020-06-30 | $211k | 6.5k | 32.57 |
2020-03-31 | $188k | 6.5k | 29.02 |
2019-12-31 | $66k | 1.9k | 35.14 |
2019-09-30 | $40k | 1.9k | 21.30 |
More positions owned by Summit Investment Advisors
View all positions for Summit Investment Advisors